Cryomass Technologies (Cryomass Technologies) ROCE % : 0.00% (As of Sep. 2023)

View and export this data going back to 2013. Start your Free Trial

What is Cryomass Technologies ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Cryomass Technologies's annualized ROCE % for the quarter that ended in Sep. 2023 was 0.00%.

Cryomass Technologies ROCE % Historical Data

The historical data trend for Cryomass Technologies's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cryomass Technologies ROCE % Chart

Cryomass Technologies Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

ROCE %

Get a 7-Day Free Trial

-165.11

-48.52

-79.03

-91.46

-101.56

Cryomass Technologies Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
ROCE %	Get a 7-Day Free Trial															-42.50	-242.60	-105.37	-1,068.77	-

Cryomass Technologies ROCE % Calculation

Cryomass Technologies's annualized ROCE % for the fiscal year that ended in Dec. 2022 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2022 )		(A: Dec. 2021 )		(A: Dec. 2022 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2022 )		(A: Dec. 2021 )		(A: Dec. 2022 )
	=	-10.297	/	( ( (15.584 - 1.882)	+	(7.863 - 1.288) )	/ 2 )
	=	-10.297	/	( (13.702	+	6.575)	/ 2 )
	=	-10.297	/	10.1385
	=	-101.56 %

Cryomass Technologies's ROCE % of for the quarter that ended in Sep. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Sep. 2023 )		(Q: Jun. 2023 )		(Q: Sep. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Sep. 2023 )		(Q: Jun. 2023 )		(Q: Sep. 2023 )
	=	-5.38	/	( ( (1.359 - 1.814)	+	(1.072 - 1.98) )	/ 2 )
	=	-5.38	/	( ( -0.455	+	-0.908 )	/ 2 )
	=	-5.38	/	-0.6815
	=	0 %

(1) Note: The EBIT data used here is four times the quarterly (Sep. 2023) EBIT data.

Cryomass Technologies (OTCPK:CRYM) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Cryomass Technologies ROCE % Related Terms

Thank you for viewing the detailed overview of Cryomass Technologies's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Cryomass Technologies (Cryomass Technologies) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cryomass Technologies Inc (OTCPK:CRYM) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

1001 Bannock Street, Suite 612, Denver, CO, USA, 80204

Website

https://www.cryomass.com

Cryomass Technologies Inc designs, manufactures, and licenses field-mobile equipment for the handling of harvested cannabis, hemp, and other high-value plant material. The company owns patented technology that utilizes liquid nitrogen to fully separate, collect and protect the high-value compounds from the harvested plant. The company's offerings include refinement systems and monitoring and control systems.

Executives

Philip Blair Mullin	officer: Chief Financial Officer	3531 SOUTH LOGAN STREET, SUITE D-357, ENGLEWOOD CO 80113
Christian Noel	director, officer: Chief Executive Officer	3531 SOUTH LOGAN ST. SUITE D-357, ENGLEWOOD CO 80113
Patricia Izabel Kovacevic	officer: GC, Corp Secy, and Head of EA	3531 SOUTH LOGAN STREET, SUITE D-357, ENGLEWOOD CO 80113
Delon Hannes Human	director	3531 SOUTH LOGAN STREET, SUITE D-357, ENGLEWOOD CO 80113
Mark Radke	director	3531 SOUTH LOGAN STREET, SUITE D-357, ENGLEWOOD CO 80113
Mario Gobbo	director	3531 SOUTH LOGAN STREET, SUITE D-357, ENGLEWOOD CO 80113